TAKHZYRO
300MG INJ SOL 1X2ML+STŘ+2J
| SÚKL code | 0238260 |
|---|---|
| Name of the product | TAKHZYRO |
| _MA_MEDICATION_DETAIL_INFO_MED_NAME i | TAKHZYRO |
| Supplement | 300MG INJ SOL 1X2ML+STŘ+2J |
| Strenght | 300MG |
| Pharmaceutical form | Solution for injection |
| Package | 1X2ML+STŘ+2J |
| Route | Subcutaneous use |
| Wrap type | Vial |
| Legal status | na lékařský předpis |
| Active substance | LANADELUMAB (LANADELUMABUM) |
| ATC group | B06AC05 |
| ATC group name | LANADELUMAB |
Marketing authorisation information
| Registration Number | EU/1/18/1340/001 |
|---|---|
| Type of MA | Orphan medicinal products |
| MA status | R - active MA/authorised medicinal product |
| MA Holder | Takeda Pharmaceuticals International AG Ireland Branch, Dublin |
| MA Holder country | IRSKO |
cz